HIV & Vaccines
Over the last 30 years, HIV treatment choices have vastly improved. However, medications can have negative side effects, be expensive, and be difficult to obtain in some countries. Some people may acquire drug resistance to particular HIV treatments, requiring them to switch regimens. HIV transmission can be prevented by properly using condoms and taking pre-exposure prophylaxis. However, researchers believe that the most efficient strategy to fully eliminate new HIV infections is to develop a prophylactic HIV vaccine. 1. Covid-19 2. Hepatitis B is the second most common kind of hepatitis. 3. Human papillomavirus (for those up to age 26) 4 Influenza Virus (flu) 5 meningococcal vaccines to prevent meningococcal illness 6 pneumococcal infections (pneumonia) 7 Pertussis, tetanus, and diphtheria (whooping cough). The three illnesses are all protected by a single vaccine.
Related Conference of HIV & Vaccines
HIV & Vaccines Conference Speakers
Recommended Sessions
- AIDS stigma and discrimination
- Awareness and knowledge on HIV/AIDS, STDs and STIs
- Emerging Technologies towards HIV/AIDS
- HIV & Vaccines
- HIV and Aging
- HIV and AIDS Nursing Care Management
- HIV and bone damage
- HIV and cardiovascular disease
- HIV and Retroviral Diseases
- HIV Diagnosis and Therapy
- HIV Drug Discovery and Research
- HIV in women
- HIV/AIDS Nursing and AIDS awareness
- Lived experience of HIV
- Pediatric HIV AIDS
- Venereal Diseases Prevention and Treatment
- Viral Immunology and Vaccines development
- Viral, Bacterial, Fungal & Protozoan STDs
Related Journals
Are you interested in
- Advanced Brain Death Imaging Techniques - BRAIN DEATH 2026 (France)
- Advocacy for Improved Care - BRAIN DEATH 2026 (France)
- AI and Machine Learning in Diagnosis - BRAIN DEATH 2026 (France)
- Collaborative Models of Brain Death Care - BRAIN DEATH 2026 (France)
- Cultural Sensitivity in Care - BRAIN DEATH 2026 (France)
- Ethics in Brain Death Diagnosis - BRAIN DEATH 2026 (France)
- Family-Centered Care Strategies - BRAIN DEATH 2026 (France)
- Global Insights on Brain Death Care - BRAIN DEATH 2026 (France)
- Innovative Neurocritical Care Approaches - BRAIN DEATH 2026 (France)
- Legal Perspectives on Brain Death - BRAIN DEATH 2026 (France)
- Neuroethics: End-of-Life Decisions - BRAIN DEATH 2026 (France)
- Neuromonitoring Innovations - BRAIN DEATH 2026 (France)
- Neurorehabilitation for Survivors - BRAIN DEATH 2026 (France)
- Neuroscience Revolution: Latest Breakthroughs - BRAIN DEATH 2026 (France)
- Novel Therapies for Brain Death Patients - BRAIN DEATH 2026 (France)
- Organ Donation Challenges and Solutions - BRAIN DEATH 2026 (France)
- Palliative Care Strategies - BRAIN DEATH 2026 (France)
- Public Awareness Campaigns - BRAIN DEATH 2026 (France)
- Research Translation to Practice - BRAIN DEATH 2026 (France)
- Supporting Patients and Families - BRAIN DEATH 2026 (France)